ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (TAK US)

5
Analysis
Health CareJapan
Takeda Pharmaceutical Company Limited is engaged in research and development, manufacturing, sales and marketing, and import and export of pharmaceutical drugs. The Company focuses on the core therapeutic areas of oncology, gastrointestinal, and central nervous system disease.
more
Refresh
bullishSilver
22 Apr 2024 05:32

Silver Measured Move to 35.50

Gold looks a bit fatigued and silver likely to play catch up. Greenback could present headwinds for equities. Japan reverses big gains in 2024.

Logo
252 Views
Share
25 Aug 2020 13:36

Takeda Sells Japan OTC Business to Blackstone; Last of Its Non-Core Asset Sales to Raise US$10bn

Takeda announced on Monday (24th August 2020) that it has entered into an agreement to sell its domestic consumer health business (known as Takeda...

Share
16 Jun 2020 23:10

TOPIX Inclusion (9273 JP): Koa Shoji Holdings

Koa Shoji Holdings (9273 JP)  confirmed (J-only) on 15th June they had received approval to move from the Second Section to the First Section of...

Share
29 Apr 2020 14:02

Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas

On 24th April, Takeda Pharmaceutical announced that it has entered into an agreement to sell off a portfolio of select non-core over the counter...

Share
02 Apr 2020 18:57

J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways

In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...

Share
No more insights
x